Leucorrhoea

Reading Document
Medical Text Search

leucorrhoea causes types diagnosis management

Medical Text Search

vaginal discharge differential diagnosis pathological physiological

GradeResponse
GradeResponse
The retrieval returned limited results. Drawing on the Harrison's reference and my own comprehensive clinical knowledge to provide a thorough overview.

Leucorrhoea

Leucorrhoea refers to a whitish or yellowish vaginal discharge. It is one of the most common gynaecological complaints and may be physiological or pathological.

Classification

TypeDescription
PhysiologicalNormal discharge; no infection or pathology
PathologicalAbnormal discharge due to infection, inflammation, or neoplasia

Physiological Leucorrhoea

Occurs in response to normal hormonal fluctuations. It is typically white/clear, non-offensive, non-irritating, and does not require treatment.
Common settings:
  • Neonatal period (maternal oestrogen influence)
  • Puberty (rising oestrogen)
  • Mid-cycle (around ovulation — increased, clear, stretchy discharge)
  • Premenstrual phase
  • Pregnancy (increased vascularity and glandular activity)
  • Sexual arousal
  • Oral contraceptive pill use

Pathological Leucorrhoea

Causes by Source

SourceConditions
VulvaVulvitis, contact dermatitis
VaginaBacterial vaginosis (BV), trichomoniasis, candidiasis, foreign body, atrophic vaginitis
CervixCervicitis (Chlamydia, Gonorrhoea), cervical ectropion, cervical polyp, cervical carcinoma
UterusEndometritis, submucous fibroid, endometrial carcinoma, IUCD
TubesSalpingitis (PID), pyosalpinx

Differential Diagnosis of Common Vaginal Discharges

FeatureBacterial VaginosisTrichomoniasisVulvovaginal Candidiasis
OrganismGardnerella vaginalis + anaerobesTrichomonas vaginalisCandida albicans
ColourGrey/whiteYellow-green, frothyWhite, "cottage cheese"
OdourFishy (amine)OffensiveOdourless or yeasty
pH>4.5>4.5<4.5 (normal)
Itching/irritationMinimalMarkedIntense pruritus
KOH "whiff test"PositiveMay be positiveNegative
MicroscopyClue cellsMotile trichomonadsPseudohyphae, spores
TreatmentMetronidazole 400 mg BD × 7 days (or 2 g single dose)Metronidazole 2 g single dose (treat partner)Clotrimazole vaginal cream/pessary or Fluconazole 150 mg oral
(Harrison's, p. 4077)

Clinical Assessment

History

  • Onset, duration, amount
  • Colour, consistency, odour
  • Associated symptoms: pruritus, dysuria, dyspareunia, pelvic pain, intermenstrual/postcoital bleeding
  • Sexual history, contraception, recent antibiotics
  • Menstrual and obstetric history

Examination

  • Per speculum: assess discharge character, cervical appearance (ectropion, polyp, contact bleeding)
  • Bimanual: uterine/adnexal tenderness (suggests PID)

Investigations

  • Vaginal pH (lateral wall swab)
  • Wet mount/saline preparation: clue cells, trichomonads
  • KOH preparation: pseudohyphae (candida)
  • High vaginal swab (HVS) for culture
  • Endocervical swab / NAAT for Chlamydia and Gonorrhoea
  • Pap smear if indicated
  • Pelvic ultrasound (if PID, fibroids, or endometrial pathology suspected)

Specific Management

Bacterial Vaginosis

  • Metronidazole 400–500 mg orally BD × 7 days or 2 g single dose
  • Alternatives: Clindamycin 300 mg BD × 7 days, or vaginal clindamycin cream
  • Partner treatment not routinely recommended

Trichomoniasis

  • Metronidazole 2 g oral single dose (treat partner simultaneously)
  • Alternative: Tinidazole 2 g single dose

Vulvovaginal Candidiasis

  • Uncomplicated: Clotrimazole 500 mg pessary (single dose) or Fluconazole 150 mg oral
  • Recurrent (≥4 episodes/year): Fluconazole 150 mg weekly × 6 months
  • Avoid precipitating factors: antibiotics, tight synthetic clothing, diabetes

Cervicitis (Chlamydia/Gonorrhoea)

  • Chlamydia: Doxycycline 100 mg BD × 7 days (or Azithromycin 1 g single dose)
  • Gonorrhoea: Ceftriaxone 500 mg IM single dose
  • Treat sexual partner(s); abstain until treatment complete

Atrophic Vaginitis (post-menopausal)

  • Topical oestrogen (cream, pessary, or ring)

Complications if Untreated

  • Ascending infection → PID → tubo-ovarian abscess, chronic pelvic pain, ectopic pregnancy, infertility
  • Preterm labour (BV in pregnancy)
  • Increased HIV susceptibility (disrupted vaginal flora)
  • Psychological distress

Key Points

  • Always distinguish physiological from pathological before initiating treatment.
  • Vaginal pH is a simple, rapid first test: normal pH <4.5 suggests candidiasis; elevated pH >4.5 points to BV or trichomoniasis.
  • In sexually active women with mucopurulent cervical discharge, empirical treatment for both Chlamydia and Gonorrhoea is appropriate pending NAAT results.
  • Always screen for STIs when a pathological cause is identified.
This is a shared conversation. Sign in to Orris to start your own chat.